InsidersTradesSigma
Follow the 成大生物 share price and the full insider trade history of the company, a listed equity based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 成大生物 has logged 2 insider filings. Market capitalisation: €8.2bn. The latest transaction was reported on 11 April 2023 (Purchase). Among the most active insiders: 崔建伟. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
成大生物 es una empresa del sector de la salud y farmacéutico, que cotiza en la Bolsa de Shanghái. Se centra en la investigación y el desarrollo de productos biológicos y farmacéuticos.